chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was seen by Dr. on 10/20/2023 for right shoulder pain and decreased ROM.  She stated that she received her flu shot at our clinic on 9/29/2023 and it was very painful.  Stated she continued to have pain, but waited for the pain to resolve, which it did not.  Hence, she was seen 3 weeks later.  Dr. placed patient on Meloxicam 15mg daily and referred her to Orthopedic Clinic for further treatment.  Patien thas an appointment on 11/17/2023 with MD at Orthopedic clinic.  The vaccine was administered by Senior Nursing Student during her Community Health Clinical roation.  Patient did not complain of pain to this nurse or to the the Nursing Student who administered the vaccine. Nursing Instructor and I met with student and reviewed her technique in administering vaccines which was appropriate.  The patient is very small in stature, weight and bone structure so this may have factored into the shoulder injury while being vaccinated per Dr.  This nurse spoke with patient on 10/21/2023 and aske how she was feeling.  Patient stated she continued to have pain and some decreased ROM in her R Shoulder.  Patient stated she had not started the Meloxicam yet, but would start in the following day.  Attempted to call patient today (10/27/2023) but had to leave message for her to call me back.  Patient diagnosed with Bursitis of Right Shoulder by Dr.
Approx 33 hours post vaccine I had excruciating pain at my injection site that radiated through my shoulder and into my shoulder blade. 10/10 for pain. Approx two hours after I had a severe fever 101-103, chills, vomiting, and all over muscle pain. I?ve had consistent body tingling since then. This lasted about 7 hours while taking Tylenol and Advil.
1046 Hep A vaccine given to pt with no distress noted. 1047 pt fell face first to floor with rigidity, stiffness noted, eyes rolled back in head, passed out, assisted to catch pt but pt hit face (R) side to floor. Within 5 sec pt turned over on back, legs shaky, rigidity diminished fever, no rigidity. Pt then alert and oriented x 3. Pt stated he was ok. Pt verbalized eating the same. No history fainting.
This spontaneous case reported by a consumer, describes the occurrence of rash and pruritus (itching on her arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006C21A and 037C21A) for COVID-19 immunization. No medical history reported. On Apr 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 22, 2021, patient experienced rash and pruritus (itching on her arm). At the time of the report, rash and pruritus (itching on her arm) outcome: unknown. No concomitant and treatment medications provided.
Patient had hives develop on her left arm. No SOB. Lung clear bilaterally. Mother administered 12.5mg oral Benadryl.
Varivax injection given 8-2-07 called office 8-3-07 with c/o red raised quarter to halk dollar size bump, warm to touch & itchy @ injection site. Pt seen in office on 8-4-07 for worsening symptoms of 9x9cm area of reddness, @ right tricep area with a more central 3x4cm deeper reddness and swelling with itching, fever and soreness. To use ice, advil, or script for vicoden given.
Breakthrough case admission after 3 vaccines  Pfizer 1/8/21 lot# EL0140;  Pfizer 1/29/21 lot# EL8982;  Pfizer 10/4/21 lot# FA6780
pt recv vax;following vax, exp rash & enlarged,tender,red testicles;
DIZZINESS, NAUSEA, TINGLING/ NUMBNESS OF LIPS AND MOUTH AND BODY, FELT UNSTEADY ON HER FEET
ringing in his ears / tinnitus; Lethargy; tenderness at injection site; redness and tenderness at injection site; This case was reported by a consumer and described the occurrence of tinnitus in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th September 2020, the patient received the 1st dose of Shingrix. In September 2020, 5 days after receiving Shingrix, the patient experienced tinnitus. On 29th September 2020, the patient experienced lethargy, injection site tenderness and injection site erythema. On 21st December 2020, the outcome of the tinnitus was recovered/resolved. On an unknown date, the outcome of the lethargy, injection site tenderness and injection site erythema were recovered/resolved.   It was unknown if the reporter considered the tinnitus to be related to Shingrix. The reporter considered the lethargy, injection site tenderness and injection site erythema to be related to Shingrix.  Additional details were provided as follows: It was reported that patient received the 1st dose of Shingrix and 5 days after the vaccination patient experienced ringing in the ears. One day after the vaccination patient experienced lethargy and redness and tenderness at injection site. The events lasted for few days and later resolved. The reporter did not consent to follow up. This case was linked with US2020AMR253566 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR253566:
sore arm, headache, nausea, worsened tinnitus (I developed tinnitus in my right ear along with some hearing loss when I received my first does on 3/30/21)
Pt left arm developed redness, swelling and tenderness. Upper left arm. Pt was treated with Prednisone.
My arm was painful at the injection site all day on the date it occurred 0900 09/17/2021. Within 10 hours the arm pain began to increase, along with body aches all over and a strong headache. By 2100 on 09/17/2021 I had horrible body aches, chills, headache and was completely exhausted and also had a fever of 100.1 degrees.  Difficulty sleeping due to the hot/cold cycle of fever and chills. Symptoms continued into the next day 09/18/2021 in which I continued to feel exhausted, felt body aches, seemed to have a fever still and arm pain persisted. By 09/19/2021 I felt less tired and less body pain and no fever but still had reduced amount of energy, and still continued pain at injection site and still sporadic headache. Today 09/20/2021 as of 0900, I still have pain in arm at injection site, low energy but better than over the weekend, no fever or chills today.
On 04/21/2000 the patient developed chickenpox. The patient was treated with Zovirax. Additional information has been requested.
Fever and chills on 12/15; severe muscle and joint aches; hand swelling and pain, stiff neck. Fever and chills were one night only. The rest persisted but with less severity. Everything but the stiff neck and upper back is okay now.
The adverse event that led me to fill out this form: Temperature of 99.4, in the evening two days later; I measure my temperature daily in the evening  and it's usually in the range 97.2-98.3. Temperature was normal the first two evenings. I also checked  the following morning (today) and it's normal again. Other adverse events: Ache, soreness, etc in left arm, for about two days. Ache in left wrist, right after the vaccination; I'd had pain there the previous week. Muscle spasms in my left flank, not uncomfortable, just weird; intermittently for the rest of the day.
The morning of April 3, staff at the Clinic discovered a discrepancy in the preparation of Pfizer vaccine doses. It was discovered that several undiluted vaccine doses were administered. Staff accounted for all unused undiluted vaccine doses. Unfortunately, 10 undiluted vaccine doses had been administered to patients and were not able to be retrieved. This patient received one of the undiluted doses.   The medical team contacted the CDC to determine the potential side effects and observation requirements of receiving an undiluted vaccine. The CDC confirmed that the recipients of the undiluted doses may experience stronger side effects and symptoms than someone who received the diluted dose (sore arm, flu-like symptoms, etc.).  The site public health officer spoke with suspected recipients of the undiluted vaccine to explain potential medical side effects. The Health District will follow up to monitor their status.
02/08/2021- A few days after the vaccine, my left inner arm developed hives. It then got bigger and moved around but remained on left arm only, called allergist. Hives gone by 02/14/2021.
This spontaneous report as received from a physician refers to a 17 year old male patient. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On an unknown date, the patient was vaccinated with the dose of VAQTA injection (dose, route of administration, lot# and expiration date were not reported). On an unknown date (reported as after the dose of VAQTA was administered), the patient experienced seizure. The outcome of seizure and the causality between seizure and VAQTA were not provided. Upon internal review, the event of seizure was considered to be medically significant. Additional information has been requested.
Temp up to 106F within 48 hrs responded to Tylenol & is afebrile now.
Child turned pale, stared off like petit mal sx, sow response to verbal stimuli, placed in recumbent position, b/p fell 66/33, administered epinephrine and Benadryl IM b/p improved capillary filling 1 sec., then had second staring episode, about 15-20min after medications, oxygen applied 5/l/min by nasal cannula, paramedics called and transported to ER, child never loss consciousness, no respiratory distress, no wheezing, capillary filling just before paramedics arrived 2-3 sec. no
Pt said that ever since she got vaccine her arm has been sore and has nerve pain. She said it lasted 3 weeks.
After a couple of days, I noticed a loss of my sense of taste. Went to the doctor where it was determined I may have contracted it at the vaccination site and should quarantined. Since I had no other symptoms I got a COVID test and waited it out. The test did come back negative but I err on the side of caution and stayed in quarantine. By 4/20/2021 I was released from quarantine and felt fine.
This spontaneous report as received from a registered nurse refers to a patient of unknown age. On 29-MAY-2012 the patient was vaccinated with GARDASIL dose 3, .5 ml, intramuscular. This third dose was administered too closely to the second dose. First dose was administered on 28-DEC-2011, second dose on 28-FEB-2012 and third dose on 29-MAY-2012. No further information was available. Additional information has been requested.
After immunization, patient immediately felt nausea and complaint of tingling down (r) arm.  Patient was very anxious, also complaint of (r) arm burning.  Patient takes Gabapetin, Flexaril, ibuprofen.  Patiet felt light headedness.   Smoker, anxiety, hiatal hernia, chronic neck pain, history of shoulder surgery.
No further AE; Medical Tech calls to report vaccine given during an excursion.  No PQC. No further AE  TE Case02454494; This spontaneous report was received from a pharmacy technician (also reported as medical tech) and refers to a patient of unknown demographics.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 16-AUG-2023, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, albumin status: recombinant human albumin (rHA), lot #w038812, expiration date reported and confirmed as 04-JUN-2024 (dose, route and site of administration not provided) administered one time for prophylaxis.  It was reported that the administered dose was given during a temperature excursion that it had underwent for unreported amount of time on unreported temperature (product storage error). No further adverse event (AE) (no adverse event).
2-1/2-3 " diameter raised red areas on upper arm at injection site. Hot to touch, tender, and firm.
Facial and arm rash Friday 2/5 at 7:00 pm Facial and arm rash Saturday 2/6 @ 5:08 PM Benadryl taken / self medicated - rash  went away
Overdose; Inappropriate schedule of vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of overdose in a 2-month-old male patient who received HBV (Engerix B adult) (batch number N73FA, expiry date 30-JAN-2023) for prophylaxis.   Concomitant products included HEPATITIS B VACCINE (ENGERIX-B PEDIATRIC).   On 14-DEC-2022, the patient received the 2nd dose of Engerix B adult (rt. vastus lateralis) 1 ml. On 14-DEC-2022, an unknown time after receiving Engerix B adult, the patient experienced overdose (Verbatim: Overdose) and adult product administered to child (Verbatim: Inappropriate schedule of vaccine). The outcome of the overdose and adult product administered to child were unknown.   Additional Information: GSK receipt date: 2-Aug-2023 Medical assistant called to inquired that how to proceed with Hepatitis B series. On 3rd May 2023, the patient's mom stated that the patient received 3 shots that day (3rd May 2023) and health care professional thought one might have been an Engerix pediatric dose but there was no documentation or record and was unknown if an Engerix dose was administered. Did not consent to follow-up. The pediatric patient inadvertently received an adult dose of Engerix-B, which led to overdose and adult product administered to child.
Information has been received from a certified medical assistant for the pregnancy registry for GARDASIL, concerning a 16 year old female who on 27-JUL-2007 was vaccinated with the first dose of GARDASIL, 0.5 mL, I.M. and on 05-OCT-2007 with the second dose of GARDASIL. On 14-MAR-2008, the patient was scheduled to receive a third dose of the series, but the patient had a positive pregnancy test and the third dose was not given. On 17-MAR-2008, the patient had a miscarriage of the pregnancy. The reporter stated that the patient has since become pregnant again. On an unspecified date, positive pregnancy test since having miscarriage was performed (WAES # 0809USA01854). The patient sought unspecified medical attention. Upon internal review, miscarriage of the pregnancy was determined to be an other important medical event. Additional information has been requested.
Information has been received from a registered pharmacist concerning a male who on 05-FEB-2010 was vaccinated with a dose of ZOSTAVAX (Oka/Merck). On 15-MAR-2010 the patient developed a rash "all over his body" which looked similar to a "Henoch-Schonlein" rash. The patient received unspecified medical attention. At the time of the report, the patient's status was unknown. Upon internal review, "Henoch-Schonlein" rash was considered to be an other important medical event. No further information is available.
Myalgia, Fever & CoughWheeze Narrative: PT was self-treating fever at home with appropriated OTC medications/dosage
No other AE occurred; an expired dose of PROQUAD was administered to the patient on 9/6/2022; This spontaneous report was received from a Licensed Practical Nurse concerning to a patient of unspecified age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 06-SEP-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant Human Albumin (rHA), 1 dose, lot #U007505, expiration date: 04-SEP-2022 (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis (expired product administered).  No other adverse events occurred (no adverse event).
pt recv vax;devel inject site rxn characterized by pain,warmth,swelling & redness;
pt recv vax & 4JUL98 devel cellulitis @ the site of vax; pt severely immunocompromised but improved w/ATB;
In March 1st I received my first COVID vaccine. I was given the Phizer vaccine. My second vaccine appt was cancelled by the provider due to limited number of vaccines. It was unclear when they would get more in so I began looking for other providers. I rescheduled with another provider but didn?t realize they were administering Moderna. I went to the vaccine site and although there was prescreening, they did not catch that I had received the Phizer until after they administered the dose. So far I have not experienced side effects.
Pt. deltoid muscle swelled immediately after Tdap injected to approximately 50 mm in diameter. Deltoid muscle was red. Ice was applied. Pt. reported no pain, 50mg oral BENADRYL given. Dr. evaluated pt.
Hepatitis A vaccine given on 5-02-06 and repeated on 06-06-06. Pt has had no adverse reaction to date. No treatment was given.
Stomach ache, chills and diaharrea within 24 hours of getting the vaccine.
This spontaneous report as received from a Licensed Vocational Nurse regarding unspecified patients of unknown age. There was no information about concurrent condition and historical medication. On30-SEP-2015, the patient were vaccinated with ZOSTAVAX lot # L006381, 25-MAY-2016 which were exposed to temperatures outside of the recommended range. No adverse event was reported. No concomitant medication was reported. The outcome of the event was unknown. Additional information has been requested.
tested positive for Covid; This is a spontaneous report from a contactable consumer (patient's wife) through the Pfizer-sponsored program. This consumer reported similar events for two patients. This is the second of the two reports.  A male patient (reporter's husband) of an unspecified age received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient and his wife got the first dose on 20Jan2021 and tested positive for COVID on 25Jan2021. The patient's wife wanted to know if it was okay for her and her husband to still get the vaccine as they are scheduled to get the second dose on 10Feb2021. The outcome of the event was unknown.   Information on the Batch/Lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021147921 same reporter/drug/event, different patient.
Information has been received from a health professional concerning a 60 year old female with pre-existing allergies, birth defects and medical conditions which include: NOTUSS, LOPID, TRICOR, sulfa, CIPRO, KEFLEX, codeine, CLARITIN, AVELOX, CODICLEAR, decongestants, PREVACID, PNC, polylistfote.  Medical diagnosis included: PVD, hyperlipidemia, hypertension, GERD, HA and proteins deficiency as well as insomnia and anxiety, who on 16-OCT-2007 at 2:00 pm was vaccinated SC in the left arm with a first dose of ZOSTAVAX (Oka/Merck) (lot number: 658208/0886U).  On 16-OCT-2007 concomitant therapy included INFLUENZA VIRUS VACCINE (USP) (lot number: U250ZAA) in which she was vaccinated IM at 2:00 pm in the right deltoid.  On 16-OCT-2007 the patient experienced red, raised with heat, local rx around the injection site with no pain or itching.  Treatment included: apply ice as much as possible, take ZYRTEC 1 daily for 10 days and follow-up if symptoms persist.  On 22-OCT-2007 all symptoms were gone except for sore around injection site.  The outcome was reported as recovered.  There was no illness at time of vaccination.  There was no product quality complaint.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/21/2007. Follow-up information indicated that "all patient's symptoms resolved after 1-4 days of getting vaccine". Additional information has been requested.
10/14/08: patient received Fluvirin in left deltoid 10/30/08: patient went to see physician for complaint of pain in left arm. Pain started 2 days after receiving injection. Physician reported no obvious lesion, no erythema or warm of shoulder; and patient has full range of motion. Physician concluded "probably reaction to flu injection and prescribed Celebrex. 11/04/08: Patient came in to store and reported her complaint. Patient stated to me that she still have pain in left shoulder that seems to move to different areas of her left arm such as to shoulder and arm pit, but no where else. Patient said that pain is not getting worse but decreasing at a very slow rate. Patient also stated that she has "hematoma". However, her physician's report did not indicate "hematoma". Upon examining of her arm, I did see any bruising, skin discoloration, or any other physical signs that would indicate "hematoma" or pain. 11/18/08: I called patient so check on her current condition. Patient stated that her pain has decreased, but it is still there and has not completely returned to pre-vaccination state.
Patient is 37 years old and is immunocompromised. Patient has never received the pneumonia vaccine before. Per patient's Proactive care, patient is due for Prevnar 13 but Pneumovax  23 was administered. Patient tolerated injection well and denies any signs or symptoms at time for vaccination. Spoke with patient the following day 2/24/2021 and patient denies and signs or symptoms with the Pneumovax 23 vaccine.
Nausea, Vomiting, Fever, Headache, Chills, Muscle and Joint Pain, Fatigue- Felt like I had COVID Took Zofran from previous positive COVID test.  Symptoms lasted about 8 hours.
Syncope, no trauma,  BP. 105/61. P 80. 98%  Released to home
Data exchange not properly working in office. Procedure did not include reconciliation of immunizations causing extra dose to be given.
Pt. received 1st dose Johnson & Johnson, should have received 2nd Pfizer dose.
This spontaneous report has been received from a physician, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 03-JUL-2017, the patient was vaccinated with the first dose of GARDASIL 9 intramuscularly (frequency, lot # and expiration date were not provided) for prophylaxis. Furthermore on 22-JAN-2018, the reporter stated that the patient experienced an interrupted dosing schedule in the human papillomavirus (HPV) vaccination series with the second dose of GARDASIL 9 intramuscularly (frequency, lot # and expiration date were not provided) for prophylaxis. No adverse effects reported.
Patch of skin on right forearm became very dry, red, and a inflamed for several days post-injection. My period also came approximately 7 days early and was unusually heavy (leaking through a super tampon in only 2-3 hours). It lasted for 2 days, as opposed to my usual 4 days.
Patient reported about 2 day of flu-like symptoms including low grade fevers, shooting pain in head, joint pain. After a few days she developed red spots on arms and legs. 2 of these spots blistered. She saw Dr. who did lab work to rule out other causes and felt that her symptoms were a reaction to the SHINGRIX vaccine. She continues to have symptoms 1 week later, though legs are a bit less itchy with steroid cream applied and she was able to do some of her normal daily activities today.
Patient reported itchy red blotches forming on the administration arm within 24 hours of administration. She reports that it has improved since first appearing, so I advised she take Benadryl and seek medical care if it does not continue to improve.